BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

261 related articles for article (PubMed ID: 34599019)

  • 21. Atypical Teratoid/Rhabdoid Tumor: Revisiting Histomorphology and Immunohistochemistry With Analysis of Cyclin D1 Overexpression and
    Sali AP; Epari S; Nagaraj TS; Sahay A; Chinnaswamy G; Shetty P; Moiyadi A; Gupta T
    Int J Surg Pathol; 2021 Apr; 29(2):155-164. PubMed ID: 32703045
    [No Abstract]   [Full Text] [Related]  

  • 22. Sampling From the Proteome to the Human Leukocyte Antigen-DR (HLA-DR) Ligandome Proceeds Via High Specificity.
    Mommen GP; Marino F; Meiring HD; Poelen MC; van Gaans-van den Brink JA; Mohammed S; Heck AJ; van Els CA
    Mol Cell Proteomics; 2016 Apr; 15(4):1412-23. PubMed ID: 26764012
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Immunotherapy in atypical teratoid-rhabdoid tumors: Data from a survey of the HGG-Immuno Group.
    van Gool SW; Holm S; Rachor J; Adamson L; Technau A; Maass E; Frühwald MC; Schlegel PG; Eyrich M
    Cytotherapy; 2016 Sep; 18(9):1178-86. PubMed ID: 27421737
    [TBL] [Abstract][Full Text] [Related]  

  • 24. T cells of colorectal cancer patients' stimulated by neoantigenic and cryptic peptides better recognize autologous tumor cells.
    Schwarz S; Schmitz J; Löffler MW; Ghosh M; Rammensee HG; Olshvang E; Markel M; Mockel-Tenbrinck N; Dzionek A; Krake S; Arslan B; Kampe KD; Wendt A; Bauer P; Mullins CS; Schlosser A; Linnebacher M
    J Immunother Cancer; 2022 Dec; 10(12):. PubMed ID: 36460334
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Atypical Teratoid/Rhabdoid Tumor (AT/RT) Arising From Ependymoma: A Type of AT/RT Secondarily Developing From Other Primary Central Nervous System Tumors.
    Nobusawa S; Hirato J; Sugai T; Okura N; Yamazaki T; Yamada S; Ikota H; Nakazato Y; Yokoo H
    J Neuropathol Exp Neurol; 2016 Feb; 75(2):167-74. PubMed ID: 26769252
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Integrative -omics and HLA-ligandomics analysis to identify novel drug targets for ccRCC immunotherapy.
    Reustle A; Di Marco M; Meyerhoff C; Nelde A; Walz JS; Winter S; Kandabarau S; Büttner F; Haag M; Backert L; Kowalewski DJ; Rausch S; Hennenlotter J; Stühler V; Scharpf M; Fend F; Stenzl A; Rammensee HG; Bedke J; Stevanović S; Schwab M; Schaeffeler E
    Genome Med; 2020 Mar; 12(1):32. PubMed ID: 32228647
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Direct interrogation of viral peptides presented by the class I HLA of HIV-infected T cells.
    Yaciuk JC; Skaley M; Bardet W; Schafer F; Mojsilovic D; Cate S; Stewart CJ; McMurtrey C; Jackson KW; Buchli R; Olvera A; Cedeño S; Plana M; Mothe B; Brander C; West JT; Hildebrand WH
    J Virol; 2014 Nov; 88(22):12992-3004. PubMed ID: 25165114
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Atypical teratoid/rhabdoid tumors (ATRTs) with SMARCA4 mutation are molecularly distinct from SMARCB1-deficient cases.
    Holdhof D; Johann PD; Spohn M; Bockmayr M; Safaei S; Joshi P; Masliah-Planchon J; Ho B; Andrianteranagna M; Bourdeaut F; Huang A; Kool M; Upadhyaya SA; Bendel AE; Indenbirken D; Foulkes WD; Bush JW; Creytens D; Kordes U; Frühwald MC; Hasselblatt M; Schüller U
    Acta Neuropathol; 2021 Feb; 141(2):291-301. PubMed ID: 33331994
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Central nervous system atypical teratoid/rhabdoid tumors of infancy and childhood.
    Rorke LB; Packer R; Biegel J
    J Neurooncol; 1995; 24(1):21-8. PubMed ID: 8523069
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Absence of oncogenic canonical pathway mutations in aggressive pediatric rhabdoid tumors.
    Kieran MW; Roberts CW; Chi SN; Ligon KL; Rich BE; Macconaill LE; Garraway LA; Biegel JA
    Pediatr Blood Cancer; 2012 Dec; 59(7):1155-7. PubMed ID: 22997201
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Brachyury expression in intracranial SMARCB1-deficient tumors: important points for distinguishing poorly differentiated chordoma from atypical teratoid/rhabdoid tumor.
    Kohashi K; Yamamoto H; Yamada Y; Kinoshita I; Oda Y
    Hum Pathol; 2021 Jun; 112():1-8. PubMed ID: 33741347
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Molecular genetics of atypical teratoid/rhabdoid tumor.
    Biegel JA
    Neurosurg Focus; 2006 Jan; 20(1):E11. PubMed ID: 16459991
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A meta-analysis of HLA peptidome composition in different hematological entities: entity-specific dividing lines and "pan-leukemia" antigens.
    Backert L; Kowalewski DJ; Walz S; Schuster H; Berlin C; Neidert MC; Schemionek M; Brümmendorf TH; Vucinic V; Niederwieser D; Kanz L; Salih HR; Kohlbacher O; Weisel K; Rammensee HG; Stevanovic S; Walz JS
    Oncotarget; 2017 Jul; 8(27):43915-43924. PubMed ID: 28159928
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Overexpression of TEAD4 in atypical teratoid/rhabdoid tumor: New insight to the pathophysiology of an aggressive brain tumor.
    Suzuki M; Kondo A; Ogino I; Arai H; Tomita T; Sredni ST
    Pediatr Blood Cancer; 2017 Jul; 64(7):. PubMed ID: 27966820
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Maternal embryonal leucine zipper kinase immunoreactivity in atypical teratoid/rhabdoid tumors: a study of 50 cases.
    Ravindra N; Rao S; Arivazhagan A; Santosh V
    Childs Nerv Syst; 2021 Dec; 37(12):3769-3775. PubMed ID: 34611764
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Identification of RPL5 and RPL10 as novel diagnostic biomarkers of Atypical teratoid/rhabdoid tumors.
    Ren Y; Tao C; Wang X; Ju Y
    Cancer Cell Int; 2018; 18():190. PubMed ID: 30479569
    [TBL] [Abstract][Full Text] [Related]  

  • 37. SWI/SNF complex heterogeneity is related to polyphenotypic differentiation, prognosis, and immune response in rhabdoid tumors.
    Panwalkar P; Pratt D; Chung C; Dang D; Le P; Martinez D; Bayliss JM; Smith KS; Adam M; Potter S; Northcott PA; Mascarenhas L; Shows J; Pawel B; Margol A; Huang A; Judkins AR; Venneti S
    Neuro Oncol; 2020 Jun; 22(6):785-796. PubMed ID: 31912158
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Multimodal treatments combined with gamma knife surgery for primary atypical teratoid/rhabdoid tumor of the central nervous system: a single-institute experience of 18 patients.
    Ren YM; Wu X; You C; Zhang YK; Li Q; Ju Y
    Childs Nerv Syst; 2018 Apr; 34(4):627-638. PubMed ID: 29218405
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A role for fluorescence in situ hybridization detection of chromosome 22q dosage in distinguishing atypical teratoid/rhabdoid tumors from medulloblastoma/central primitive neuroectodermal tumors.
    Bruch LA; Hill DA; Cai DX; Levy BK; Dehner LP; Perry A
    Hum Pathol; 2001 Feb; 32(2):156-62. PubMed ID: 11230702
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Primary diffuse leptomeningeal atypical teratoid/rhabdoid tumor diagnosed by cerebrospinal fluid cytology: case report with molecular genetic analysis.
    Tomomasa R; Nakata S; Nobusawa S; Horiguchi K; Matsumura N; Ikota H; Hirato J; Yoshimoto Y; Yokoo H
    Hum Pathol; 2018 Jul; 77():116-120. PubMed ID: 29339179
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.